CDC73 and tumor of parathyroid gland: The combined findings of negative parafibromin staining and HRPT2 gene abnormalities increase the likelihood of a malignancy.(45,82) Based on this reasoning, it seems appropriate to evaluate all parathyroid tumors in which the diagnosis is uncertain for abnormalities of both the HRPT2 gene and its product, parafibromin.